Cargando…

Guselkumab: widened action in psoriatic disease

Detalles Bibliográficos
Autores principales:	Arnone, Marcelo, de Carvalho, André Vicente Esteves, Fabricio, Lincoln Zambaldi, Romiti, Ricardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Faculdade de Medicina / USP 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8075108/ https://www.ncbi.nlm.nih.gov/pubmed/33978074 http://dx.doi.org/10.6061/clinics/2021/e2629

Ejemplares similares

Paradoxical psoriatic arthritis flare with the initiation of brodalumab and guselkumab
por: Kashlan, Reem, et al.
Publicado: (2021)

Guselkumab-induced vitiligo in a patient with psoriatic arthritis
por: Martora, Fabrizio, et al.
Publicado: (2023)

Population pharmacokinetics and exposure‐response modeling analyses of guselkumab in patients with psoriatic arthritis
por: Chen, Yang, et al.
Publicado: (2021)

Clinical Characteristics of Registry Participants with Psoriatic Arthritis Initiating Guselkumab: An Analysis from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry
por: Mease, Philip J., et al.
Publicado: (2022)

Widening the concept of oncogene
por: Casas-Tintó, Sergio, et al.
Publicado: (2016)

Effectiveness, survival and safety of guselkumab attending to basal characteristics in moderate-to-severe psoriatic patients: a cohort study
por: Ruiz-Villaverde, Ricardo, et al.
Publicado: (2022)

Widening the reach of structural biology
por: Baker, Edward N.
Publicado: (2016)

Comparative effectiveness of guselkumab in psoriatic arthritis: results from systematic literature review and network meta-analysis
por: Mease, Philip J, et al.
Publicado: (2021)

A case of severe psoriatic arthritis with hands flexion contracture and palmar psoriasis successfully treated with guselkumab
por: Megna, Matteo, et al.
Publicado: (2022)

Comparative effectiveness of guselkumab in psoriatic arthritis: updates to a systematic literature review and network meta-analysis
por: Mease, Philip J, et al.
Publicado: (2022)

Efficacy of Guselkumab in Treating Nails, Scalp, Hands, and Feet in Patients with Psoriasis and Self-reported Psoriatic Arthritis
por: Orbai, Ana-Maria, et al.
Publicado: (2023)

Resolution of enthesitis by guselkumab and relationships to disease burden: 1-year results of two phase 3 psoriatic arthritis studies
por: McGonagle, Dennis, et al.
Publicado: (2021)

Practice guidelines for interstitial lung diseases: Widening the reach
por: Montesi, Sydney B.
Publicado: (2020)

A Widening Scope
Publicado: (1914)

Guselkumab for plaque psoriasis
Publicado: (2019)

Guselkumab provides sustained domain-specific and comprehensive efficacy using composite indices in patients with active psoriatic arthritis
por: Coates, Laura C, et al.
Publicado: (2022)

Composite Measures of Disease Activity in Psoriatic Arthritis: Comparative Instrument Performance Based on the Efficacy of Guselkumab in an Interventional Phase II Trial
por: Helliwell, Philip S., et al.
Publicado: (2020)

Widening the Reach of Bioethics Scholarship
por: Laurie, Graeme T.
Publicado: (2021)

Obstetric anaesthesia: Widening horizons?
por: Gupta, Sunanda
Publicado: (2010)

Six-Month Persistence and Multi-domain Effectiveness of Guselkumab in Adults with Psoriatic Arthritis: Real-World Data from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry
por: Mease, Philip J., et al.
Publicado: (2023)

Psoriatic scarring alopecia
por: Almeida, Maiana Carneiro, et al.
Publicado: (2013)

One World One Health: Widening horizons
por: Panda, Samiran, et al.
Publicado: (2021)

Inhaled Anesthetics for Sedation in ICU: Widening Horizons!
por: Krishna, Bhuvana
Publicado: (2022)

Sweden's economic inequality gap is widening and worrying
por: The Lancet Regional Health – Europe
Publicado: (2023)

Generalized pustular psoriasis (von Zumbusch)()
por: Romiti, Ricardo, et al.
Publicado: (2022)

Diabetic retinopathy screening – Widen the net, tighten the mesh
por: Honavar, Santosh G
Publicado: (2021)

Pharmacy practice: Is the gap between the North and South widening?
por: Babar, Zaheer-Ud-din, et al.
Publicado: (2012)

Are we inadvertently widening the disparity gap in pursuit of precision oncology?
por: Spratt, Daniel E.
Publicado: (2018)

Widening the scope: defining and treating moral injury in diverse populations
por: ter Heide, F. Jackie June, et al.
Publicado: (2023)

Guselkumab for the treatment of psoriasis – evidence to date
por: Nogueira, Miguel, et al.
Publicado: (2019)

Collagen Turnover Biomarkers Associate with Active Psoriatic Arthritis and Decrease with Guselkumab Treatment in a Phase 3 Clinical Trial (DISCOVER-2)
por: Schett, Georg, et al.
Publicado: (2022)

Arthritis Interception in Patients with Psoriasis Treated with Guselkumab
por: Zabotti, Alen, et al.
Publicado: (2021)

Systemic amyloidosis manifestation in a patient with psoriatic arthritis()()
por: Souza, Bruno de Castro e, et al.
Publicado: (2021)

[H1] The widened gap in mental health services during the pandemic
por: The Lancet Regional Health – Western Pacific
Publicado: (2021)

Translation and validation of the Simplified Psoriasis Index (SPI) into Brazilian Portuguese
por: de Morais, Marina Resener, et al.
Publicado: (2018)

Efficacy and Safety of Guselkumab, an Interleukin‐23p19–Specific Monoclonal Antibody, Through One Year in Biologic‐Naive Patients With Psoriatic Arthritis
por: McInnes, Iain B., et al.
Publicado: (2021)

Guselkumab Modulates Differentially Expressed Genes in Blood of Patients With Psoriatic Arthritis: Results from Two Phase 3, Randomized, Placebo‐Controlled Trials
por: Siebert, Stefan, et al.
Publicado: (2023)

Metabolic syndrome and psoriatic arthritis among patients with psoriasis vulgaris: Quality of life and prevalence
por: Souza, Cacilda S., et al.
Publicado: (2018)

Eczematous eruption after guselkumab treatment for psoriasis
por: Reyn, Birgit, et al.
Publicado: (2019)

Modified dose of guselkumab for treatment of pyoderma gangrenosum
por: Reese, Ashley M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9tua0n9lscn14evupc7mcjioqf